Breaking News Instant updates and real-time market news.

AERI

Aerie Pharmaceuticals

$61.75

0.8 (1.31%)

04:55
11/29/17
11/29
04:55
11/29/17
04:55

Aerie Pharmaceuticals management to meet with Needham

Meeting to be held in Boston on November 29 hosted by Needham.

  • 29

    Nov

  • 28

    Feb

AERI Aerie Pharmaceuticals
$61.75

0.8 (1.31%)

10/16/17
ADAM
10/16/17
NO CHANGE
Target $73
ADAM
Buy
Aerie Pharmaceuticals price target raised to $73 from $65 at Canaccord
Canaccord analyst Dewey Steadman raised his price target on Aerie Pharmaceuticals to $73 from $65 following the FDA advisory committee meeting for Rhopressa, which was overwhelmingly positive and he believes should lead to an approval by its February 2018 PDUFA date. Steadman views the company as one of the best positioned names in his coverage universe and he reiterated his Buy rating on Aerie Pharmaceuticals shares.
10/16/17
NEED
10/16/17
NO CHANGE
Target $76
NEED
Buy
Aerie Pharmaceuticals price target raised to $76 from $65 at Needham
Needham analyst Serge Belanger raised his price target on Aerie Pharmaceuticals to $76, saying the commentary from FDA's AdCom on Friday gives him greater confidence in the approval and commercial potential of Rhopressa. Belanger says Aerie Pharmaceuticals is a "prime acquisition target for larger pharma ophthalmology players given the size of the glaucoma market" - about $5B worldwide - and the potential blockbuster commercialization scenarios for the Rhopressa/Roclatan franchise. The analyst maintains a Buy rating on Aerie Pharmaceuticals stock.
10/23/17
GUGG
10/23/17
INITIATION
Target $80
GUGG
Buy
Aerie Pharmaceuticals initiated with a Buy at Guggenheim
Guggenheim analyst Adnan Butt initiated Spectrum with a Buy and $80 price target.
11/09/17
COWN
11/09/17
NO CHANGE
Target $100
COWN
Outperform
Aerie Pharmaceuticals Rhopressa approval highly likely, says Cowen
Cowen analyst Tyler Van Buren said Aeri Pharmaceuticals is accelerating the late stage commercial preparations given the potential for an earlier than expected approval of Rhopressa. Management believes the early approval is possible given the unanimously positive advisory committee meeting, the early labeling discussions, and the recent manufacturing de-risking. Van Buren reiterated his Outperform rating and $100 price target on Aeri Pharmaceuticals shares.

TODAY'S FREE FLY STORIES

MASI

Masimo

$105.29

0.44 (0.42%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Upgrade
Masimo rating change  »

Masimo upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRAM

Everspin Technologies

$6.23

0.11 (1.80%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Everspin Technologies management to meet with Needham »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

04:55
12/19/18
12/19
04:55
12/19/18
04:55
General news
Breaking General news story  »

Fed Chair Press…

04:55
12/19/18
12/19
04:55
12/19/18
04:55
General news
Breaking General news story  »

FOMC Forecasts to be…

AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

, ATTU

Attunity

$19.52

0.33 (1.72%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
William Blair software & IT services analyst to hold a group luncheon »

Software & IT…

AMZN

Amazon.com

$1,551.00

29.66 (1.95%)

ATTU

Attunity

$19.52

0.33 (1.72%)

BL

BlackLine

$39.64

1.03 (2.67%)

CRM

Salesforce

$132.29

1.44 (1.10%)

DATA

Tableau

$121.60

1.52 (1.27%)

EVBG

Everbridge

$53.96

3.51 (6.96%)

HUBS

HubSpot

$128.12

2.575 (2.05%)

MITK

Mitek Systems

$10.18

-0.2 (-1.93%)

OOMA

Ooma

$13.36

0.08 (0.60%)

PVTL

Pivotal Software

$15.49

-0.38 (-2.39%)

RDC

Rowan Companies

$8.90

-0.5 (-5.32%)

TDC

Teradata

$36.47

-0.2 (-0.55%)

TWLO

Twilio

$85.24

-2.21 (-2.53%)

ZEN

Zendesk

$55.42

-0.425 (-0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

  • 04

    Jan

  • 07

    Jan

  • 10

    Feb

  • 03

    Mar

THG

Hanover Insurance

$109.10

-0.52 (-0.47%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Hanover Insurance management to meet with Buckingham »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MRTX

Mirati Therapeutics

$38.10

-1.6 (-4.03%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Mirati Therapeutics management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 05

    Jan

WWE

WWE

$73.53

2.27 (3.19%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
WWE management to meet with MKM Partners »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

04:55
12/19/18
12/19
04:55
12/19/18
04:55
General news
Current Account to be reported at 08:30 »

Current Account will be…

IGT

International Game

$16.02

0.42 (2.69%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
International Game management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

POOL

Pool Corp.

$145.55

-0.21 (-0.14%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Pool Corp. management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

CFX

Colfax

$20.97

0.41 (1.99%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Colfax to hold a conference call »

Conference call to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MTX

Minerals Technologies

$50.86

0.69 (1.38%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Minerals Technologies management to meet with Seaport Global »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

DEI

Douglas Emmett

$34.25

0.19 (0.56%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Douglas Emmett management to meet with Evercore ISI »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Morgan Stanley REITs analyst to hold an analyst/industry conference call »

REITs Analyst Vikram Hill…

BRKS

Brooks Automation

$25.73

-0.03 (-0.12%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Brooks Automation management to meet with Stephens »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ALIM

Alimera Sciences

$0.92

-0.04 (-4.17%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Alimera Sciences management to meet with B. Riley FBR. »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ASPU

Aspen Group

$5.25

0.01 (0.19%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Aspen Group management to meet with Lake Street »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

MODN

Model N

$14.00

-0.2 (-1.41%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Model N management to meet with JMP Securities »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

OPRX

OptimizeRx

$9.74

-2.05 (-17.39%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
OptimizeRx management to meet with Roth Capital »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 18

    Dec

SILC

Silicom

$37.00

0.65 (1.79%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Silicom management to meet with Oppenheimer »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

AMRN

Amarin

$14.79

-0.76 (-4.89%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Amarin management to meet with Jefferies »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Bernstein U.S. portfolio strategist to hold analyst/industry conference call »

U.S. Portfolio Strategist…

CBS

CBS

$46.21

-0.6 (-1.28%)

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
CBS management to meet with Barrington »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

  • 20

    Dec

04:55
12/19/18
12/19
04:55
12/19/18
04:55
Conference/Events
Stephens paper/packaging analyst to hold a luncheon meeting »

Paper & Packaging…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.